PF-Atlas › Clinical Trials › NCT06853145

Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis

Hyperpolarized Xe129 · Early Phase 1

Registry ID
NCT06853145
Phase
Early Phase 1
Status
Recruiting
Drug / intervention
Hyperpolarized Xe129
Sponsor
University of Virginia
Start
2025-05-01
Enrollment
6
Locations
1

About this trial

Idiopathic pulmonary fibrosis has a poor prognosis with limited treatment options. The Investigator hypothesize hyperpolarized Xe129-MRI can be performed in patients with IPF and repeated over time which will detect deficiencies related to perfusion in the lung.

View NCT06853145 on ClinicalTrials.gov →

Explore related

All Hyperpolarized Xe129 trialsAll IPF trials

Related trials

Hyperpolarized Xe129 — NCT04677426Hyperpolarized Xe129 — NCT04624490
Medical disclaimer. This page summarizes public trial data for NCT06853145 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.